Statin Benefits Patients With Low LDL Cholesterol
Links shared publicly online about this topic.
- 2,488total visits
Statin Benefits Patients With Low LDL Cholesterol
View full resource at webmd.com
Tags: Cholesterol, Cholesterol Medication, Drug, Healthy Living, News
Most Recently Shared on November 10, 2008 at 5:24 pm By:
WebMD Health News Statin Benefits Patients With Low LDL Cholesterol: People with norm.. http://tinyurl.com/6r33a2
Positive results from Amgen's AMG 145 Phase 1b study on patients with LDL-C
news-medical.net — “Amgen announced today positive results from a Phase 1b clinical study of AMG 145, an investigational PCSK9 inhibitor, in patients with high cholesterol who were taking statins. The study demonstrated that multiple doses of AMG 145 significantly reduced serum low density lipoprotein cholesterol (LDL-C), also known as "bad" cholesterol, by up to 81 percent versus placebo (maximum reduction) in subjects on low to moderate doses of statins/” View full resource at news-medical.net
Most Recently Shared on March 26, 2012 at 8:32 am By:
Arthritis News: Positive results from Amgen's AMG 145 Phase 1b study on patients with LDL-C: Amgen announced tod... http://t.co/ZuH7jy7d
WHAT TO DO ABOUT NIACIN? NOTHING….AGAIN. Advice Information Review SmarterHeartUniversity.com Radio
smarterheartuniversity.com — “WHAT TO DO ABOUT NIACIN? NOTHING….AGAIN. Advice Information Review SmarterHeartUniversity.com Radio” View full resource at smarterheartuniversity.com
Most Recently Shared on November 28, 2011 at 2:20 pm By:
Coronary Artery Calcium Might Help Identify Low-Risk Patients Who Would Benefit from Statins - General Medicine
general-medicine.jwatch.org — “In the placebo-controlled JUPITER trial (JW Gen Med Nov 18 2008), rosuvastatin (Crestor) significantly lowered the incidence of adverse cardiovascular events in healthy patients with normal levels of LDL cholesterol (<130 mg/dL) and . . .” View full resource at general-medicine.jwatch.org
Most Recently Shared on August 31, 2011 at 1:27 pm By:
Juliet Mavromatis Doctor, Internist, and Physician
On the fence about treating your cholesterol with medicine ? A coronary artery calcium determination might help... http://t.co/OOldWkm
New Study Questions Health Benefits of Commonly Prescribed Cholesterol-Lowering Medication Ezetimibe in Some Patients
newswise.com — “A new study by University of Virginia Health System researchers adds to mounting evidence that ezetimibe may not halt significant artery wall thickening, or atherosclerosis, in some patients. Despite the medication--™s proven effectiveness in lowering LDL cholesterol, UVA researchers found a notable progression of atherosclerosis in patients who added ezetimibe to their pre-existing cholesterol-lowering statin medication therapy.” View full resource at newswise.com
Most Recently Shared on May 19, 2011 at 2:16 pm By:
New Study Questions Health Benefits of Commonly Prescribed Cholesterol-Lowering Medication Ezetimibe in S... http://bit.ly/jjpzFZ #heart
Statin-Treated Patients with Mixed Dyslipidemia Benefit from Concomitant Omega-3 Fatty Acids - MPR
empr.com — “The addition of omega-3 fatty acids (POM3) to atorvastatin increased low-density lipoprotein particle (LDL-P) size without altering LDL-P concentration in patients with mixed dyslipidemia, results of a post-hoc analysis demonstrated at a ACC.11, the American College of Cardiology--™s 60th Annual Scientific Session.” View full resource at empr.com
Most Recently Shared on April 3, 2011 at 9:53 pm By:
MPR News: Statin-Treated Patients with Mixed Dyslipidemia Benefit from Concomitant Omega-3 Fatty Acids: The addi... http://bit.ly/fP6ppu
Statin-Treated Patients with Mixed Dyslipidemia Benefit from Concomitant Omega-3 Fatty Acids - ONA
oncologynurseadvisor.com — “The addition of omega-3 fatty acids (POM3) to atorvastatin increased low-density lipoprotein particle (LDL-P) size without altering LDL-P concentration in patients with mixed dyslipidemia, results of a post-hoc analysis demonstrated at ACC.11, the American College of Cardiology--™s 60th Annual Scientific Session.” View full resource at oncologynurseadvisor.com
Most Recently Shared on April 3, 2011 at 9:37 pm By:
OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education
Statin-Treated Patients with Mixed Dyslipidemia Benefit from Concomitant Omega-3 Fatty Acids http://goo.gl/fb/9WwuR
Statins: Cholesterol-Lowering Drug Does Not Benefit Low-Risk Patients | ThirdAge
thirdage.com — “Statins--"prescription drugs that lower the threat of cardiovascular disease--"may pose little benefits for people already in good health, according to a new study.” View full resource at thirdage.com
Most Recently Shared on January 19, 2011 at 9:22 pm By:
Statins: Cholesterol-Lowering Drug Does Not Benefit Low-Risk Patients http://bit.ly/e8PoXz
Statin Benefits Questioned in Low-Risk Patients - FoxNews.com
foxnews.com — “People without heart disease should think twice before taking cholesterol-lowering statins, British researchers warn in a new report ” View full resource at foxnews.com
Most Recently Shared on January 19, 2011 at 2:59 pm By:
Health,Fitness,Diet Health Business
Statin Benefits Questioned in Low-Risk Patients http://bit.ly/dM6KHv
Statin benefits questioned in low-risk patients | Reuters
reuters.com — “NEW YORK (Reuters Health) - People without heart disease should think twice before taking cholesterol-lowering statins, British researchers warn in a report out Wednesday.While the popular drugs require” View full resource at reuters.com
Most Recently Shared on January 19, 2011 at 1:51 pm By:
Stephen Meyers, MD Family Medicine Doctor, Physician, and Doctor
Statin benefits questioned in low-risk patients. Reuters - http://ow.ly/3Gq77 RT @MedThink
Statin benefits questioned in low-risk patients | Reuters
reuters.com — “NEW YORK (Reuters Health) - People without heart disease should think twice before taking cholesterol-lowering statins, British researchers warn in a report out Wednesday. While the popular drugs require” View full resource at reuters.com
Most Recently Shared on January 19, 2011 at 8:23 am By:
Bruce McLucas, MD Surgeon, Physician, Doctor, and ObGyn Physician
Statin benefits questioned in low-risk patients http://ow.ly/1aVIPR
Statin benefits questioned in low-risk patients | Reuters
reuters.com — “NEW YORK (Reuters Health) - People without heart disease should think twice before taking cholesterol-lowering statins, British researchers warn in a report out Wednesday. While the popular drugs require” View full resource at reuters.com
Most Recently Shared on January 19, 2011 at 8:18 am By:
Statin benefits questioned in low-risk patients http://bit.ly/faeium
Statin benefits questioned in low-risk patients | Reuters
reuters.com — “NEW YORK (Reuters Health) - People without heart disease should think twice before taking cholesterol-lowering statins, British researchers warn in a report out Wednesday. While the popular drugs require” View full resource at reuters.com
Most Recently Shared on January 19, 2011 at 8:08 am By:
Statin benefits questioned in low-risk patients http://reut.rs/fKGVUY
JUPITER: High-Risk Patients Benefit From Rosuvastatin - QualityPoint Technologies
qualitypointtech.net — “The data, a post hoc subgroup analysis from the JUPITER study, provides support for the recent decision by European health authorities to modestly extend the rosuvastatin label to primary-prevention patients with low LDL-cholesterol levels but who are considered high risk based on other factors. Heartwire” View full resource at qualitypointtech.net
Most Recently Shared on November 10, 2010 at 7:02 pm By:
JUPITER: High-Risk Patients Benefit From Rosuvastatin: The data, a post hoc subgroup analysis from the JUPITER stu... http://bit.ly/dn7oLU
Cholesterol Study: Low HDL May Not Be So Bad
webmd.com — “Patients on statin drugs who reduce their LDL ''bad'' cholesterol to very low levels may not need to be so concerned about boosting their HDL ''good” View full resource at webmd.com
Most Recently Shared on July 22, 2010 at 10:29 pm By:
webMD: Cholesterol Study: Low HDL May Not Be So Bad http://bit.ly/cC0N4T Full http://bit.ly/baINB5
JUPITER analysis of elderly patients
theheart.org — “The use of statin therapy in older adults with normal LDL-cholesterol levels but systemic inflammation assessed by CRP significantly reduces the risk of cardiovascular events. An editorial, however, suggests the role for CRP testing is still unknown, given that 65% of patients had hypertension, which, included with their age, would make them candidates for aggressive therapy anyway.” View full resource at theheart.org
Most Recently Shared on April 22, 2010 at 9:41 pm By:
JUPITER: Rosuvastatin benefits elderly patients, but editorialists question role for CRP: The use of statin therap... http://bit.ly/dbTqN9
Advertisement
